Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians.
dc.contributor.author | Berna-Rico, Emilio | |
dc.contributor.author | Abbad-Jaime de Aragón, Carlota | |
dc.contributor.author | García-Aparicio, Ángel | |
dc.contributor.author | Antón Rodríguez, Cristina | |
dc.contributor.author | González-Cantero, Álvaro | |
dc.date.accessioned | 2023-12-13T11:46:33Z | |
dc.date.available | 2023-12-13T11:46:33Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Patients with psoriasis have a higher prevalence of cardiovascular risk factors. This study evaluated cardiovascular screening practices and statin prescribing habits among dermatologists, rheumatologists and primary care physicians (PCPs) through an online questionnaire, which was distributed through the Spanish scientific societies of the above-mentioned specialties. A total of 299 physicians (103 dermatologists, 94 rheumatologists and 102 PCPs) responded to the questionnaire. Of these, 74.6% reported screening for smoking, 37.8% for hypertension, 80.3% for dyslipidaemia, and 79.6% for diabetes mellitus. Notably, only 28.4% performed global screening, defined as screening for smoking, hypertension, dyslipidaemia, and diabetes mellitus by the same physician, and 24.4% reported calculating 10-year cardiovascular disease (CVD) risk, probably reflecting a lack of comprehensive cardiovascular risk assessment in these patients. This study also identified unmet needs for awareness of cardiovascular comorbidities in psoriasis and corresponding screening and treatment recommendations among PCPs. Of PCPs, 61.2% reported not being aware of the association between psoriasis and CVD and/or not being aware of its screening recommendations, and 67.6% did not consider psoriasis as a risk-enhancing factor when deciding on statin prescription. Thirteen dermatologists (12.6%) and 35 rheumatologists (37.2%) reported prescribing statins. Among those who do not prescribe, 49.7% would be willing to start their prescription. | spa |
dc.description.extent | 492 KB | spa |
dc.identifier.doi | 10.2340/actadv.v103.5087 | spa |
dc.identifier.issn | 1651-2057 | spa |
dc.identifier.uri | https://hdl.handle.net/10641/3573 | |
dc.language.iso | eng | spa |
dc.publisher | Acta dermato-venereologica | spa |
dc.relation.publisherversion | https://medicaljournalssweden.se/actadv/article/view/5087 | spa |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 España | * |
dc.rights.accessRights | open access | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.subject | Cardiovascular disease | spa |
dc.subject | Diagnosis | spa |
dc.subject | Hearth disease risk factor | spa |
dc.subject | Psoriasis | spa |
dc.title | Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians. | spa |
dc.type | journal article | spa |
dc.type.hasVersion | AM | spa |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 72b2ac96-de6b-4634-aede-647e87a82b46 | |
relation.isAuthorOfPublication.latestForDiscovery | 72b2ac96-de6b-4634-aede-647e87a82b46 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Cardiovascular Screening psoriasis patients.pdf
- Size:
- 492.93 KB
- Format:
- Adobe Portable Document Format
- Description: